NCT06122428View on ClinicalTrials.gov

Efficacy of Riboflavin-Enhanced Hyaluronic Acid Eye Drops in Treating Dry Eye Disease

CompletedOBSERVATIONAL
Enrollment

16

Participants

Timeline

Start Date

February 8, 2022

Primary Completion Date

July 22, 2022

Study Completion Date

October 10, 2022

Conditions
Dry Eye Disease
Interventions
DRUG

modified hyaluronic acid 0.1% covalently linked to Riboflavin

The patients used the eye drops no less than 3 times a day or no more than 6 times a day, according to their needs. They reported the instillation frequency (3/4 or 5/6 times per day) on the provided document

DRUG

hyaluronic acid 0.1%

The patients used the eye drops no less than 3 times a day or no more than 6 times a day, according to their needs. They reported the instillation frequency (3/4 or 5/6 times per day) on the provided document

Trial Locations (1)

80131

University of Naples Federico II, Naples

All Listed Sponsors
lead

University of Naples

OTHER